Table 3.
Best Response, n (%) | BCLC-A (n=3) | BCLC-B (n=13) | BCLC-C (n=19) |
---|---|---|---|
CR | 2 | 3 | 7 |
PR | 1 | 8 | 8 |
SD | 0 | 1 | 2 |
PD | 0 | 1 | 2 |
ORR | 100% | 84.6% | 78.9% |
DCR | 100% | 92.3% | 89.4% |
Conversion to resectable HCC, n (%) | 1 (33.3) | 3 (23.1) | 10 (52.6) |
Abbreviations: mRECIST, modified Response Evaluation Criteria in Solid Tumors; BCLC, Barcelona clinic liver cancer; CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; HCC, hepatocellular carcinoma.